John S. Montalbano - 26 Nov 2025 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Director
Signature
Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
26 Nov 2025
Net transactions value
+$178,460
Form type
4
Filing time
26 Nov 2025, 14:58:20 UTC
Previous filing
16 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Montalbano John S. Director C/O ABCELLERA BIOLOGICS INC, 150 W 4TH AVENUE, VANCOUVER, BRITISH COLUMBIA, CANADA Tryn Stimart, attorney-in-fact 26 Nov 2025 0001834423

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Purchase $178,460 +50,000 +29% $3.57 221,000 26 Nov 2025 Direct
holding ABCL Common Shares 5,000 26 Nov 2025 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.